Autoantibodies against the human asialoglycoprotein receptor: Effects of therapy in autoimmune and virus-induced chronic active hepatitis
- 31 December 1993
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 19 (1) , 55-63
- https://doi.org/10.1016/s0168-8278(05)80176-x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The human hepatic asialoglycoprotein receptor is a target antigen for liver-infiltrating T cells in autoimmune chronic active hepatitis and primary biliary cirrhosisHepatology, 1990
- T-cell-directed hepatocyte damage in autoimmune chronic active hepatitisThe Lancet, 1990
- The asialoglycoprotein receptor: a model for endocytic transport receptorsBiochemistry, 1990
- Autoimmunity and Liver DiseaseHepatology, 1990
- Autoantibodies to Human Asialoglycoprotein Receptor in Autoimmune–Type Chronic HepatitisHepatology, 1990
- Antibodies Against the Hepatic Asialoglycoprotein Receptor Perfused In Situ Preferentially Attach to Periportal Liver Cells in the RatHepatology, 1990
- Analysis of liver‐specific protein LSP using murine monoclonal antibodiesEuropean Journal of Clinical Investigation, 1987
- T-CELL INDUCERS OF SUPPRESSOR LYMPHOCYTES CONTROL LIVER-DIRECTED AUTOREACTIVITYThe Lancet, 1987
- Serum autoantibodies reacting with the hepatic asialoglycoprotein receptor protein (hepatic lectin) in acute and chronic liver disordersJournal of Hepatology, 1986
- ANTIGEN SPECIFIC SUPPRESSOR CELL FUNCTION IN AUTOIMMUNE CHRONIC ACTIVE HEPATITISThe Lancet, 1984